Standardized diagnosis and treatment of thyroid nodules

doi:10.3877/cma.j.issn.1674-0785.2017.17.005

Abstract

Abstract:

Thyroid nodules refer to one or more structural abnormalities occurring in the thyroid. In clinical practice, once thyroid nodules are found, their nature should be determined through laboratory tests, diagnostic imaging, and pathological examinations to decide therapy plan. With the improvement of diagnostic and therapeutic levels and the enhancement of people′s health consciousness, the prevalence of thyroid nodules is rising. Therefore, standardized diagnosis and treatment of thyroid nodules become more important.

Key words: Thyroid nodules, Diagnosis, Treatment

Liwen Song, Xiaolong Wang, Lixia Cheng. Standardized diagnosis and treatment of thyroid nodules[J]. Chinese Journal of Clinicians(Electronic Edition), 2017, 11(17): 2189-2192.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2017.17.005

https://zhlcyszz.cma-cmc.com.cn/EN/Y2017/V11/I17/2189

References 30

[1]	Bahn RS, Castro MR. Approach to the patient with nontoxic multinodular goiter [J]. J Clin Endocrinol Metab, 2011, 96(5): 1202-1212.
[2]	American Thyroid Association(ATA) Guidelines Taskforce on Thyroid Nodules and differentiated Thyroid Cancer, Cooper DS, Doberty GM, et al. The American Thyroid Association Guidelines Taskforce. Revised management guidelines for patients with thyroid nodules and differentiated Thyroid Cancer [J]. Thyroid, 2009, 19(11): 1167-1214.
[3]	Charib H, Papini E. Thyroid Nodules: Clinical importance, assessment and treatment [J]. Endocrinol Metab Clin N Am, 2007, 36: 707-735.
[4]	邱蕾, 孙明晓, 汪耀, 等. 中年至超高龄老年人甲状腺结节的发病特点 [J]. 中华内分泌代谢杂志, 2014, 30(2): 115-118.
[5]	Wang K, Yang Y, Wu Y, et al. The association between insulin resistance and vascularization of thyroid nodules [J]. Clin Endocrinol Metab, 2015, 100(1): 184-192.
[6]	冯尚勇, 朱妍, 张真稳, 等. 江苏社区人群甲状腺结节的流行病学研究 [J]. 中华内分泌代谢杂志, 2011, 27(6): 493-494.
[7]	Xu W, Chen Z, Liu H. The association of thyroid nodules with non-iodized salt among Chinese Children [J]. PLoS One, 2014, 9(7): e102726.
[8]	潘晓芳, 孙喜岩, 贾晓东, 等. 辽宁省大连市健康体检人群甲状腺结节性疾病及其相关因素分析 [J]. 中国地方病学杂志, 2009, 28(5): 568-571.
[9]	王征, 李伟汉, 张浩, 等. 老年患者甲状腺结节与甲状腺功能的相关性 [J]. 中国老年学杂志, 2013, 33(21): 5346-5347.
[10]	邓辉, 罗义华, 钱海华. 中年至超高龄老年人群超声检查中甲状腺结节的检查情况及其与甲状腺功能的关系 [J]. 临床和试验医学杂志, 2016, 15(2): 181-184.
[11]	刘细玉, 徐江锋. 甲状腺组织内结节对131碘治疗甲状腺功能亢进疗效的影响 [J]. 中国基层医药, 2011, 18(1): 27-28.
[12]	Charib H, Papini E, Paschke R, et al. American Association of clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for clinical Practice for the Diagnosis and Management of Thyroid Nodules [J]. Endocr Pract, 2010, 16(Suppl 1): 1-43.
[13]	Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management [J]. J Clinc Endocrinol Metab, 2009, 94(5): 1748-1751.
[14]	Cibas ES, Ali SZ. The Bethesze system for reporting thyroid cytopathology [J]. Thyroid, 2009, 19(11): 1159-1165.
[15]	胡烨, 俞晓宇, 李洁. 隐匿性甲状腺癌的超声诊断和误诊分析 [J]. 中国医学影像学, 2009, 17(6): 409-411.
[16]	Baskin HJ. Thyroid ultrasound-just do it [J]. Thyroid, 2004, 14(2): 91-92.
[17]	Moon WJ, Kwag HJ, Na DG. Are there any specific ultrasound findings of nodular hyperplasia (″leave me alone″ lession) to differentiate it from follicular adenoma? [J]. ActaRadiol, 2009, 50(4): 383-388.
[18]	Moon WJ, Jung SL, Lee JH, et al. Benign and malignant thyroid nodules: US differentiation-multicenter retrospective study [J]. Radiology, 2008, 247: 762-770.
[19]	Cappelli C, Castellano M, Pirola I, et al. The predictive value of ultrasound findings in the management of thyroid nodules [J]. QJM, 2007, 100(1): 29-35.
[20]	邵伟光, 周茂义, 刘典美, 等. 宝石能谱CT测定成人甲状腺碘浓度 [J]. 中国医学影像技术, 2011, 27(12): 2389-2392.
[21]	刘佳怿, 窦晓峰, 张俊, 等. 双源CT双能量碘图对良恶性甲状腺结节的鉴别诊断价值 [J]. 中华内分泌代谢杂志, 2015, 31(4): 333-336.
[22]	李铭, 郑向鹏, 李剑颖, 等. 甲状腺结节的能谱CT研究 [J]. 中华放射学杂志, 2011, 45(8): 780-781.
[23]	张正华, 黄建强, 韩丹, 等. 双源CT平扫碘值鉴别甲状腺良恶性结节的临床应用 [J]. 肿瘤防治研究, 2015, 42(1): 52-55.
[24]	中华医学会内分泌学分会. 甲状腺结节和分化型甲状腺癌诊治指南 [J]. 中华内分泌代谢杂志, 2012, 28(10): 779-797.
[25]	Xing M, Haugen BR, Schlumberger M. Progress in molecular-based management of differentiated thyroid cancer [J]. Lancet, 2013, 381(9871): 1058-1069.
[26]	Rodrigues HG, DE PAA, Adan LF. Contribution of the BRAF oncogene in the pre-operative phase of thyroid carcinoma [J]. Oncol Lett, 2013, 6(1): 191-196.
[27]	张于芝, 徐婷, 李霄, 等. TIRADS、BSRTC与BRAFV600ET检测在甲状腺结节良恶性病变鉴别诊断中的比较研究 [J]. 中华内分泌代谢杂志, 2016, 32(5): 380-385.
[28]	中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组. 中国甲状腺疾病诊治指南-甲状腺疾病的实验室及辅助检查 [J]. 中华内科杂志, 2007, 46(8): 697-702.
[29]	Kim D, Park JW. Clinical implications of preoperative thyrotropin serum concentrations in patients who underwent thyroidectomy for nonfunctioning nodule(s) [J]. J Korean Surg Soc, 2013, 85(1): 15-19.
[30]	胡欣, 李春瑞, 徐书航, 等. 2015年美国甲状腺学会儿童甲状腺结节与分化型甲状腺癌管理指南的介绍 [J]. 中华内分泌代谢杂志, 2016, 32(4): 265-268.

Please choose a citation manager

Content to export